Dexcom INC Form 4 insider transactions

NASDAQ

11 Mar 2024

DXCM

Form 4: Dexcom Executive Matthew Dolan Reports Stock Grant and Holdings

Executive Vice President of Strategy and Corporate Development at Dexcom, Matthew Vincent Dolan, reports the acquisition of 21,711 shares of restricted stock units.

NASDAQ

11 Mar 2024

DXCM

Dexcom INC

Form 4: Dexcom Executive Michael Jon Brown Reports Acquisition of Restricted Stock Units

EVP and Chief Legal Officer of Dexcom, Michael Jon Brown, reports the acquisition of 21,711 restricted stock units.